HMS Capital Management’s ExxonMobil XOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,500
Closed -$147K 122
2021
Q3
$147K Buy
+2,500
New +$142K 0.07% 119
2020
Q3
Sell
-2,100
Closed -$93K 167
2020
Q2
$93K Buy
+2,100
New +$94.2K 0.04% 152
2020
Q1
Sell
-2,600
Closed -$181K 168
2019
Q4
$181K Sell
2,600
-2,600
-50% -$180K 0.08% 150
2019
Q3
$405K Buy
5,200
+2,600
+100% +$188K 0.15% 147
2019
Q2
$199K Hold
2,600
0.09% 144
2019
Q1
$210K Sell
2,600
-2,600
-50% -$198K 0.09% 146
2018
Q4
$399K Buy
5,200
+2,600
+100% +$204K 0.2% 123
2018
Q3
$221K Buy
2,600
+800
+44% +$65.4K 0.11% 168
2018
Q2
$149K Buy
+1,800
New +$143K 0.08% 172
2017
Q4
Sell
-2,300
Closed -$189K 155
2017
Q3
$189K Sell
2,300
-6,800
-75% -$540K 0.16% 109
2017
Q2
$735K Buy
9,100
+200
+2% +$16.4K 0.65% 54
2017
Q1
$735K Buy
8,900
+3,600
+68% +$301K 0.67% 58
2016
Q4
$478K Buy
5,300
+1,000
+23% +$87.4K 0.5% 77
2016
Q3
$375K Buy
+4,300
New +$381K 0.37% 90

Other funds holding XOM

HMS Capital Management's XOM Position: Q2 2026 in Review

HMS Capital Management held its ExxonMobil (XOM) position steady in Q2 2026 at 2,873 shares worth $393K. The position accounts for 0.15% of the portfolio, ranked #94.

HMS Capital Management first reported a position in XOM in Q3 2016 and has held it in 33 quarters since. The position peaked at $1.03M in Q4 2016. 1,143 funds tracked by Wall St. Rank hold XOM as of Q2 2026.

  • HMS Capital Management held 2,873 shares of ExxonMobil worth $393K as of Q2 2026.
  • HMS Capital Management left its ExxonMobil share count unchanged in Q2 2026.
  • ExxonMobil made up 0.15% of HMS Capital Management's portfolio in Q2 2026, its #94 holding.
  • HMS Capital Management first reported a position in ExxonMobil in Q3 2016 and has held it in 33 quarters since.
  • HMS Capital Management's ExxonMobil position peaked at $1.03M in Q4 2016.
  • 1,143 funds tracked by Wall St. Rank held ExxonMobil as of Q2 2026.

Based on HMS Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.